Remove Drugs Remove Packaging Remove Pharma Production Remove Sales
article thumbnail

Japanese drugmakers make greener packaging pledge

pharmaphorum

Four Japanese drugmakers – Astellas, Eisai, Daiichi Sankyo, and Takeda – have joined forces in a partnership intended to reduce the environmental impact of pharmaceutical packaging. It started using the sugarcane in its irritable bowel syndrome (IBS) drug Irribow (ramosetron), sold in Japan.

Packaging 105
article thumbnail

Leading freeze-drying systems suppliers for the pharmaceutical industry

Pharmaceutical Technology

They offer security in pharmaceutical manufacturing by fulfilling the security rules such as process control settings and specific requirements for the collection of batch production and control records, based on which the pharma products should be produced.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Compared with other emerging pharmaceutical markets (such as India and China, covered in previous Emerging Market Outsourcing Reports), Russian facilities lack many US Food and Drug Administration (FDA) and European Medicines Agency (EMA) approvals, meaning Russian manufacturing is more focused on the domestic market.

article thumbnail

Top PCD Pharma Franchise Companies in India

Creogenic Pharma

Therefore, it is a reason we own more than 200+ products that are DCGI approved and certified by commendable institutions like FSSAI. Our Pharma Franchise version relies on Monopoly rights, Real rates & no massive sale goal. They are also among the PCD pharma firms in India that operate across all levels of the industry.

article thumbnail

Brazil: untapped market for big pharma manufacturing

Pharmaceutical Technology

Brazilian pharma production sites are involved in Covid-19 vaccine and therapy manufacture. Oswaldo Cruz Foundation will package the drug in its facility in Rio de Janeiro before supplying it to the Brazilian public health system; the company is also involved in clinical trials for the drug’s possible use as Covid-19 prophylaxis.